Stalled TPP Gives Generics More Time To Push Back
This article was originally published in PharmAsia News
Executive Summary
Generic drug makers and others who oppose certain portions of the Trans-Pacific Partnership free-trade deal will have more time to try to convince negotiators and ministers to change course after the 12 nations involved failed to reach an agreement at what the USTR had hoped would be the final meeting in Hawaii.